v3.26.1
Stockholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2026
Stockholders Equity Note [Abstract]  
Summary of Stock Option Activity

A summary of stock option activity under the Company’s current equity incentive plans during the three month period ended March 31, 2026, was as follows:

 

 

 

Stock Options Outstanding

 

 

 

Number of
Underlying Shares

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Life (in years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding on January 1, 2026

 

 

621,539

 

 

$

2.81

 

 

 

5.37

 

 

$

3,004,897

 

Granted

 

 

-

 

 

$

-

 

 

 

-

 

 

 

-

 

Forfeited / Canceled

 

 

-

 

 

$

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

(15,313

)

 

$

3.05

 

 

 

-

 

 

$

(69,174

)

Outstanding on March 31, 2026

 

 

606,226

 

 

$

2.81

 

 

 

5.23

 

 

$

2,935,723

 

Exercisable as of March 31, 2026

 

 

456,226

 

 

$

2.76

 

 

 

4.60

 

 

$

2,242,723

 
Schedule of Grant Date Fair Value of Options Vested and the Intrinsic Value of Options Exercised The following table presents the grant date fair value of options vested and the intrinsic value of options exercised:

 

 

 

For the Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Grant date fair value of options vested

 

$

734,604

 

 

$

931,460

 

Intrinsic value of options exercised

 

$

106,890

 

 

$

233,850

 

 

 

 

 

 

 
Schedule of RSU Activity

The Company’s RSU activity for the three months ended March 31, 2026, was as follows:

 

 

 

Restricted Stock Units

 

 

 

Number of
Underlying Shares

 

 

Weighted
Average Grant
Date Fair Value

 

Unvested on January 1, 2026

 

 

997,647

 

 

$

3.32

 

Granted

 

 

429,366

 

 

$

9.66

 

Vested

 

 

(259,165

)

 

$

3.46

 

Canceled

 

 

(23,235

)

 

$

2.78

 

Unvested on March 31, 2026

 

 

1,144,613

 

 

$

5.68

 
Summary of Stock-Based Compensation Expense Associated with Continuing Operations

Stock-based compensation expense associated with continuing operations for the three month periods ended March 31, 2026 and 2025, was comprised of the following:

 

 

 

For the Three Months Ended March 31,

 

Stock-based compensation classified as:

 

2026

 

 

2025

 

General and administrative

 

$

405,360

 

 

$

408,246

 

Production

 

 

39,440

 

 

 

21,421

 

Marketing and selling

 

 

145,437

 

 

 

91,770

 

Research and development

 

 

64,891

 

 

 

56,968

 

 

 

$

655,128

 

 

$

578,405